Home
>
National Drug Code (NDC)
>
Lunesta
Lunesta - 21695-226-30 - (eszopiclone)
Drug Information of Lunesta
| Product NDC: | 21695-226 |
| Proprietary Name: | Lunesta |
| Non Proprietary Name: | eszopiclone |
| Active Ingredient(s): | 3 mg/1 & nbsp; eszopiclone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lunesta
| Product NDC: | 21695-226 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021476 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090101 |
Package Information of Lunesta
| Package NDC: | 21695-226-30 |
| Package Description: | 30 TABLET, COATED in 1 CARTON (21695-226-30) |
NDC Information of Lunesta
| NDC Code | 21695-226-30 |
| Proprietary Name | Lunesta |
| Package Description | 30 TABLET, COATED in 1 CARTON (21695-226-30) |
| Product NDC | 21695-226 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | eszopiclone |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090101 |
| Marketing Category Name | NDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | ESZOPICLONE |
| Strength Number | 3 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
